PDB: 1856 resultsInfo pagesStatus searchChemie searchBIRD

---

8S9G	SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, Processed angiotensin-converting enzyme 2, S309 Fab Heavy chain, ... Authors: Park, Y.J, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler, D. Deposit date: 2023-03-28 Release date: 2023-10-04 Method: ELECTRON MICROSCOPY (3 Å) Cite: Neutralization, effector function and immune imprinting of Omicron variants. Nature, 621, 2023
8S9Z	Mpro inhibitors of SARS-CoV-2 Descriptor: 3C-like proteinase nsp5, Mpro inhibitor Authors: Blankenship, L.R, Liu, W.R. Deposit date: 2023-03-30 Release date: 2024-04-03 Method: X-RAY DIFFRACTION (1.6 Å) Cite: Structure of MPI89 with Mpro of SARS-CoV-2 at 1.85A resolution. To Be Published
8STY	Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI60 Descriptor: 3C-like proteinase nsp5, benzyl (3S)-3-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-2-azaspiro[4.4]nonane-2-carboxylate Authors: Blankenship, L.B, Liu, W.R. Deposit date: 2023-05-11 Release date: 2023-08-30 Last modified: 2024-05-01 Method: X-RAY DIFFRACTION (1.9 Å) Cite: A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease. J.Med.Chem., 66, 2023
8STZ	Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI37 Descriptor: 3C-like proteinase nsp5, benzyl (3S)-3-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-2-azaspiro[4.5]decane-2-carboxylate Authors: Blankenship, L.B, Liu, W.R. Deposit date: 2023-05-11 Release date: 2023-08-30 Last modified: 2024-05-01 Method: X-RAY DIFFRACTION (1.85 Å) Cite: A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease. J.Med.Chem., 66, 2023
8SG6	SARS-CoV-2 Main Protease (Mpro) H163A Mutant Reduced with 20mM TCEP Descriptor: 3C-like proteinase nsp5, GLYCEROL Authors: Tran, N, McLeod, M.J, Barwell, S, Kalyaanamoorthy, S, Ganesan, A, Holyoak, T. Deposit date: 2023-04-11 Release date: 2023-09-27 Method: X-RAY DIFFRACTION (2.49 Å) Cite: The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease. Nat Commun, 14, 2023
8Q94	Crystal structure of The SARS-COV-2 BA.2.75 RBD with neutralizing-VHHs Re32D03 and Ma3B12 Descriptor: Nanobody Ma3B12, Nanobody Re32D03, Spike protein S1 Authors: Aksu, M, Guttler, T, Gorlich, D. Deposit date: 2023-08-19 Release date: 2023-12-20 Last modified: 2023-12-27 Method: X-RAY DIFFRACTION (2.5 Å) Cite: Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters. Antiviral Res., 221, 2023
8Q93	Crystal structure of the SARS-COV-2 RBD with neutralizing-VHHs Re30H02 and Re21D01 Descriptor: Nanobody Re21D01, Nanobody Re30H02, Spike protein S1 Authors: Aksu, M, Guttler, T, Rymarenko, O, Gorlich, D. Deposit date: 2023-08-19 Release date: 2023-12-20 Last modified: 2023-12-27 Method: X-RAY DIFFRACTION (3.1 Å) Cite: Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters. Antiviral Res., 221, 2023
8Q95	Crystal structure of the SARS-CoV-2 BA.1 RBD with neutralizing-VHHs Ma16B06 and Ma3F05 Descriptor: Nanobody Ma16B06, Nanobody Ma3F05, Spike protein S1 Authors: Aksu, M, Rymarenko, O, Guttler, T, Gorlich, D. Deposit date: 2023-08-19 Release date: 2023-12-20 Last modified: 2023-12-27 Method: X-RAY DIFFRACTION (1.6 Å) Cite: Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters. Antiviral Res., 221, 2023
8TMA	Antibody N3-1 bound to RBD in the up conformation Descriptor: N3-1 Fab heavy chain, N3-1 Fab light chain, Spike glycoprotein Authors: Hsieh, C.-L, McLellan, J.S. Deposit date: 2023-07-29 Release date: 2024-01-17 Method: ELECTRON MICROSCOPY (3.2 Å) Cite: SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode. Commun Biol, 6, 2023
8TM1	Antibody N3-1 bound to RBDs in the up and down conformations Descriptor: N3-1 Fab heavy chain, N3-1 Fab light chain, Spike glycoprotein Authors: Hsieh, C.-L, McLellan, J.S. Deposit date: 2023-07-27 Release date: 2024-01-17 Method: ELECTRON MICROSCOPY (2.79 Å) Cite: SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode. Commun Biol, 6, 2023
8TOR	ACE2-peptide 2 complex Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... Authors: Christie, M, Payne, R.J. Deposit date: 2023-08-03 Release date: 2024-02-07 Method: X-RAY DIFFRACTION (2.2 Å) Cite: Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity. Acs Chem.Biol., 19, 2024
8TYO	Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein Authors: Bruch, E.M, Rak, A. Deposit date: 2023-08-25 Release date: 2024-02-07 Method: ELECTRON MICROSCOPY (2.75 Å) Cite: Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2. Sci Rep, 14, 2024
8TOS	ACE2-peptide 6 complex Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, CHLORIDE ION, ... Authors: Christie, M, Payne, R. Deposit date: 2023-08-03 Release date: 2024-02-07 Method: X-RAY DIFFRACTION (2.35 Å) Cite: Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity. Acs Chem.Biol., 19, 2024
8TYL	Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein Authors: Bruch, E.M, Rak, A. Deposit date: 2023-08-25 Release date: 2024-02-07 Method: ELECTRON MICROSCOPY (2.85 Å) Cite: Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2. Sci Rep, 14, 2024
8TOQ	ACE2-peptide 1 complex Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, CHLORIDE ION, ... Authors: Christie, M, Payne, R.J. Deposit date: 2023-08-03 Release date: 2024-02-07 Method: X-RAY DIFFRACTION (2.3 Å) Cite: Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity. Acs Chem.Biol., 19, 2024
8TOU	ACE2-peptide 2 complex crystal form 3 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, ... Authors: Franck, C, Payne, R.J, Christie, M. Deposit date: 2023-08-04 Release date: 2024-02-07 Method: X-RAY DIFFRACTION (3.1 Å) Cite: Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity. Acs Chem.Biol., 19, 2024
8TOT	ACE2-peptide2 complex crystal form 2 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Angiotensin-converting enzyme 2, ... Authors: Christie, M, Payne, R.J. Deposit date: 2023-08-03 Release date: 2024-02-07 Method: X-RAY DIFFRACTION (2.8 Å) Cite: Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory Activity. Acs Chem.Biol., 19, 2024
8UAC	CATHEPSIN L IN COMPLEX WITH AC1115 Descriptor: Cathepsin L, N-[(2S)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide Authors: Chao, A, DuPrez, K.T, Han, F.Q. Deposit date: 2023-09-20 Release date: 2024-02-07 Method: X-RAY DIFFRACTION (1.4 Å) Cite: CATHEPSIN L IN COMPLEX WITH AC1115 To be Published
8SPJ	Crystal Structure of SARS-CoV-2 Main Protease (Mpro) N28T Mutant Descriptor: 3C-like proteinase nsp5 Authors: Kohaal, N, Lewandowski, E.M, Wang, J, Chen, Y. Deposit date: 2023-05-03 Release date: 2023-05-24 Last modified: 2024-05-22 Method: X-RAY DIFFRACTION (2.08 Å) Cite: Crystal Structure of SARS-CoV-2 Main Protease (Mpro) N28T Mutant To Be Published
8SXO	Crystal Structure of SARS-CoV-2 Main Protease (Mpro) H164I Mutant Descriptor: 3C-like proteinase nsp5 Authors: Kohaal, N, Lewandowski, E.M, Wang, J, Chen, Y. Deposit date: 2023-05-23 Release date: 2023-06-14 Last modified: 2024-05-22 Method: X-RAY DIFFRACTION (2.76 Å) Cite: Crystal Structure of SARS-CoV-2 Main Protease (Mpro) H164I Mutant To Be Published
8Q4O	RNA G-quadruplex from the 5'-UTR of human tyrosine kinase 2 (TYK2) Descriptor: RNA (5'-R(*CP*GP*GP*UP*AP*GP*CP*GP*GP*GP*UP*AP*UP*GP*GP*GP*UP*CP*CP*GP*GP*GP*U)-3') Authors: Toplishek, M, Kocman, V. Deposit date: 2023-08-07 Release date: 2024-03-06 Method: SOLUTION NMR Cite: High-Resolution Structure of RNA G-Quadruplex Containing Unique Structural Motifs Originating from the 5'-UTR of Human Tyrosine Kinase 2 (TYK2). Acs Omega, 9, 2024
8QQ0	SARS-CoV-2 S protein bound to neutralising antibody UZGENT_A3 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... Authors: Remaut, H, Reiter, D, Vandenkerckhove, L, Acar, D.D, Witkowski, W, Gerlo, S. Deposit date: 2023-10-03 Release date: 2024-01-31 Method: ELECTRON MICROSCOPY (3.5 Å) Cite: Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted. Ebiomedicine, 100, 2024
8QPR	SARS-CoV-2 S protein bound to human neutralising antibody UZGENT_G5 Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, IgG heavy chain - FAB, ... Authors: Remaut, H, Reiter, D, Vandenkerckhove, L, Acar, D.D, Witkowski, W, Gerlo, S. Deposit date: 2023-10-03 Release date: 2024-01-31 Method: ELECTRON MICROSCOPY (3.8 Å) Cite: Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted. Ebiomedicine, 100, 2024
6XCA	Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C105 Descriptor: C105 Heavy Chain, C105 Light Chain, SULFATE ION Authors: Sharaf, N.G, Barnes, C.O, Bjorkman, P.J. Deposit date: 2020-06-08 Release date: 2020-07-01 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell, 182, 2020
6XHU	Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design Descriptor: 3C-like proteinase Authors: Kneller, D.W, Coates, L, Kovalevsky, A. Deposit date: 2020-06-19 Release date: 2020-07-01 Last modified: 2023-10-18 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL M pro : insights into enzyme mechanism and drug design. Iucrj, 7, 2020

<25262728293031323334353637383940>